Cardeon är ett investmentbolag som investerar i bolag inom life science i tidig fas.
Har ni glömt bort SinterCast? Traton och Volvo har rusat på börsen.
Mendus has reported gross proceeds of c SEK69.1m from the exercise of series TO3 warrants that were ...
Redeye adjusts the Fair value range and Base case after the outcome of the rights issue has been con...
Core objectives, including divestments and securing bond refinancing completed One new divestment an...
Train Alliance förvärvar mark som är strategiskt utvald för järnvägsändamål.
Duell’s Q2 net sales came in at EUR 28.2m, above our estimate of EUR 25.
Redeye had a conversation with the founders of Strax after the latest divestments of Clickr to Matte...
Redeye takes a positive stance towards Avensia’s ambitious yet reasonable financial targets.
Redeye is optimistic about the new agreement with MSD/Merck to provide Keytruda for the combination ...
Ökat fotfäste i marknaden Nettoomsättningen i kvartalet visade att bolaget ökade fotfästet i marknad...
Redeye views today's press release from Lifecare positively, announcing that it has reached the targ...
Redeye comments on events in the fourth quarter report, including progress with bacterial vaccine pr...
Redeye retains its Base Case despite cutting its short-term EBIT forecasts slightly.
Hansa’s preliminary Q1 result suggests that Idefirix records European product sales of SEK 48 (43m i...
Nettoomsättningen uppgick till 62,0 MSEK (59,0) i det tredje kvartalet (november-januari) i Purefuns...
- Confirms a long-term obesity and diabetes device contract - No material impact next 2Y, ~SEK 700m ...
Duell publishes its Q2/24 results on Thursday 4th of April.
Redeye is favorable to the communicated new order by Waystream just after the market closed on Thurs...
Redeye retains its positive view on Hexatronic and keeps its outlook for Hexatronic regarding Q1 and...